News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
216 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17894)
Month
January (2488)
February (2603)
March (3229)
April (2950)
May (3962)
June (3500)
July (2854)
August (3142)
September (3205)
October (3540)
November (3386)
December (2332)
Day
2 (186)
3 (175)
4 (147)
5 (166)
6 (119)
9 (121)
10 (183)
11 (172)
12 (142)
13 (112)
14 (38)
15 (1)
16 (171)
17 (154)
18 (148)
19 (149)
20 (92)
21 (2)
23 (153)
24 (148)
25 (216)
26 (204)
27 (119)
28 (2)
29 (9)
30 (193)
31 (218)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
2
3
4
5
6
9
10
11
12
13
14
15
16
17
18
19
20
21
23
24
25
26
27
28
29
30
31
Drug Development
Biogen Announces AFFINITY Phase II Trial Initiation for Opicinumab (Anti-LINGO-1) in Multiple Sclerosis
The study was designed to evaluate opicinumab as an investigational add-on therapy in people with relapsing multiple sclerosis (MS).
October 25, 2017
·
6 min read
Business
Nine-Month Figures for 2017: Sartorius Continues to Grow Profitably in a Challenging Environment
Sartorius, a leading international partner of the biopharmaceutical industry and research, recorded further growth in the first nine months of 2017 despite a partly challenging business environment.
October 25, 2017
·
9 min read
Pharm Country
Newron Pharmaceuticals to Present at European Rett Syndrome Congress and Host Advisory Board Meeting
Newron Pharmaceuticals S.p.A. today announced an oral presentation at the upcoming European Rett Syndrome Congress (“the congress”) in Berlin, Germany, November 2-4, 2017.
October 25, 2017
·
8 min read
Business
GenSight Biologics Appoints Barrett Katz as Chief Medical Officer
Dr. Katz replaces Mohamed Genead, M.D., who resigned from the position for personal reasons.
October 25, 2017
·
4 min read
Genetown
NantHealth’s Vitality Mobile App Now Available on Apple and Android Devices
NantHealth today announced that its Vitality Mobile app is now available for download through the Apple and Google Play Stores.
October 25, 2017
·
5 min read
Business
Unchained Labs Bulks Up the Board, Adds Max Carnecchia
Unchained Labs announced the appointment of Max Carnecchia to its Board today.
October 25, 2017
·
1 min read
Philips Announces Findings of Patient Experience in Imaging Research
Royal Philips today announced the key findings of its research focused on the patient experience in diagnostic imaging procedures.
October 25, 2017
·
4 min read
Business
Blueprint Medicines to Report Third Quarter 2017 Financial Results on Tuesday, October 31, 2017
Blueprint Medicines today announced that it will host a live conference call and audio webcast at 8:30am ET on Tuesday, October 31, 2017 to report its third quarter 2017 financial results and provide a corporate update.
October 25, 2017
·
1 min read
Business
Precision Global Names Ethan Zink to its North American Sales Team
Precision Global today announced that Ethan Zink joined Precision’s North American Sales Team as Sales Account Manager for the Northeast Region on October 9, 2017.
October 25, 2017
·
1 min read
Genetown
Six New Companies Select SHYFT to Maximize Launch Success of Specialty and Rare Disease Brands
SHYFT Analytics today announced that in the last quarter, six biopharma companies have chosen to launch their new therapies using the SHYFT Platform.
October 25, 2017
·
2 min read
Previous
14 of 22
Next